Geneva, April 27 -- International Clinical Trials Registry received information related to the study (NCT07533799) titled 'The Swedish BioFINDER Sleep Study' on April 1.
Study Type: Observational
Primary Sponsor: Skane University Hospital
Condition:
Parkinson's Disease
REM Sleep Behavior Disorder (iRBD)
Lewy Body Disease
Synucleinopathy
Synucleinopathies
Intervention:
Diagnostic Test: Dopamine transporter PET scan with [18F]FE-PE2I
Diagnostic Test: Magnetic resonance imaging (MRI)
Diagnostic Test: [123I] MIBG scintigraphy of the heart
Diagnostic Test: a-synuclein seeding amplification assays
Diagnostic Test: Polysomnography
Recruitment Status: Recruiting
Date of First Enrollment: October 1, 2021
Target Sample Size: 650
Countr...